Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease Academic Article uri icon


MeSH Major

  • Bone Marrow Transplantation
  • Graft vs Host Disease
  • Interleukins
  • Intestine, Small
  • Stem Cells


  • Little is known about the maintenance of intestinal stem cells (ISCs) and progenitors during immune-mediated tissue damage or about the susceptibility of transplant recipients to tissue damage mediated by the donor immune system during graft versus host disease (GVHD). We demonstrate here that deficiency of recipient-derived IL-22 increased acute GVHD tissue damage and mortality, that ISCs were eliminated during GVHD, and that ISCs as well as their downstream progenitors expressed the IL-22 receptor. Intestinal IL-22 was produced after bone marrow transplant by IL-23-responsive innate lymphoid cells (ILCs) from the transplant recipients, and intestinal IL-22 increased in response to pretransplant conditioning. However, ILC frequency and IL-22 amounts were decreased by GVHD. Recipient IL-22 deficiency led to increased crypt apoptosis, depletion of ISCs, and loss of epithelial integrity. Our findings reveal IL-22 as a critical regulator of tissue sensitivity to GVHD and a protective factor for ISCs during inflammatory intestinal damage.

publication date

  • August 24, 2012



  • Academic Article



  • eng

PubMed Central ID

  • PMC3477611

Digital Object Identifier (DOI)

  • 10.1016/j.immuni.2012.05.028

PubMed ID

  • 22921121

Additional Document Info

start page

  • 339

end page

  • 50


  • 37


  • 2